Enter assignee name

Forward Citations = 69

Loading Chart...

4 inventors (with patents filed for the assignee):

Arasteh Ari Azhir (8 out of 14 patents)

William Allen Boulanger (5 out of 15 patents)

Michael S McGrath (3 out of 26 patents)

4. Clifford A Lingwood (2 out of 18 patents)

8 patents: Sort by Forward Citations

1. 9839650 - Chlorite formulations, and methods of preparation and use thereof (2017-12-12),

2. 9579346 - Treatment of macrophage-related disorders (2017-02-28),

3. 9266734 - Chlorite formulations and methods of preparation and use thereof (2016-02-23),

4. 9023845 - Compositions and methods for treating lysosomal disorders (2015-05-05),

5. 8501244 - Chlorite formulations and methods of preparation and use thereof (2013-08-06),

6. 8252789 - Compositions and methods for treating lysosomal disorders (2012-08-28),

7. 8231856 - Chlorite formulations and methods of preparation and use thereof (2012-07-31),

8. 8067035 - Chlorite formulations, and methods of preparation and use thereof (2011-11-29),

Neuraltus Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing novel therapeutics for neurodegenerative diseases. The company's lead candidate, NP001, is being investigated for the treatment of Amyotrophic Lateral Sclerosis (ALS) and other disorders. Neuraltus is committed to advancing innovative treatments to improve the lives of patients with serious neurological conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

8 Patents

#9 in San Bruno, CA

#8,278 in California

#34,852 in US

San Bruno, CA, United States of America

Neuraltus Pharmaceuticals, Inc.

Forward Citations = 69

4 inventors:

Arasteh Ari Azhir (8 out of 14 patents)

William Allen Boulanger (5 out of 15 patents)

Michael S McGrath (3 out of 26 patents)

4. Clifford A Lingwood (2 out of 18 patents)

Please report any incorrect information to support@idiyas.com